Long-lasting intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia: 3-year pharmacological management

Journal of Internal Medicine

Volumn 252, Issue 3, 2002, Pages 271-275

  Coppola, A ^a   De Stefano, V ^a   Tufano, A ^a   Nardone, G ^a   Amoriello, A ^b   Cerbone, A M ^a   Di Minno, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

Author keywords

Angiodysplasia; Glanzmann's trombasthenia; Intestinal bleeding; Mucosal vascular abnormalities; Octreotide; Oestrogen; Progesterone; Therapy

Indexed keywords

CONJUGATED ESTROGEN; ETHINYLESTRADIOL PLUS NORETHISTERONE; ETHINYLESTRADIOL PLUS NORGESTREL; OCTREOTIDE;

AGED; ANGIODYSPLASIA; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD TRANSFUSION; CASE REPORT; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG WITHDRAWAL; ELECTROCOAGULATION; ENDOSCOPY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GLANZMANN DISEASE; HUMAN; INTESTINE MUCOSA; JEJUNUM; LARGE INTESTINE; MELENA; PATIENT CARE; PRIORITY JOURNAL; RECURRENT DISEASE; SMALL INTESTINE; VASCULAR DISEASE;

AGED; ANEMIA; ANGIODYSPLASIA; BLOOD TRANSFUSION; DRUG THERAPY, COMBINATION; ELECTROCOAGULATION; ESTRADIOL CONGENERS; ETHINYL ESTRADIOL; FEMALE; GASTROINTESTINAL AGENTS; HEMOSTATICS; HUMANS; INTESTINAL DISEASES; MELENA; NORETHINDRONE; OCTREOTIDE; PROGESTERONE CONGENERS; RECURRENCE; THROMBASTHENIA; TREATMENT OUTCOME;

EID: 0036378380     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2002.01023.x     Document Type: Article

References (16)

1. Foutch PG. Angiodysplasia of the gastrointestinal tract. Am J Gastroenterol 1993; 88: 807-18.
2. Ramsay DM, Macleod DAD, Buist TAS, Heading RC. Persistent gastrointestinal bleeding due to angiodysplasia of the gut in von Willebrand's disease. Lancet 1976; 2: 275-8.
3. Bronner MH, Pate MB, Cunningham JT, Marsh WH. Estrogen-progesterone therapy for bleeding gastrointestinal telangiectasias in chronic renal failure. An uncontrolled trial. Ann Intern Med 1986; 105: 371-4.
4. Chey WD, Hasler WL, Bockenstedt PL. Angiodysplasia and von Willebrand's Disease type IIb treated with estrogen/progesterone therapy. Am J Hematol 1992; 41: 276-9.
5. Veyradier A, Balian A, Wolf M et al. Abnormal von Willebrand Factor in bleeding angiodysplasias of the digestive tract. Gastroenterology 2001; 120: 346-53.
6. 2 anatagonists and placebo in the management of acute nonvariceal upper gastrointestinal haemorrhage: a metanalysis. Ann Intern Med 1997; 127: 1062-71.
7. Danesi R, Del Tacca M. The effects of the somatostatin analog octreotide on angiogenesis in vitro. Metabolism 1996; 45 (Suppl. 1): 49-50.
8. Nardone G, Rocco A, Balzano T, Budillon G. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther 1999; 13: 1429-36.
9. Marshall JK, Hunt RH. Hormonal therapy for bleeding gastrointestinal mucosal vascular abnormalities: a promising alternative. Eur J Gastroenterol Hepatol 1997; 9: 521-5.
10. Cerbone AM, Cirillo F, Coppola A et al. Persistent impairment of platelet aggregation following cessation of a short course dietary supplementation of moderate amounts of N-3 fatty acid ethyl-esters. Thromb Haemost 1999; 82: 128-33.
11. Livio M, Mannucci PM, Viganò G et al. Conjugated estrogens in the management of bleeding associated with renal failure. N Engl J Med 1986; 315: 731-5.
12. Barkin JS, Ross BS. Medical therapy for chronic gastrointestinal bleeding of obscure origin. Am J Gastroenterol 1998; 93: 1520-4.
13. Okamura T, Kanaji T, Osaki K, Kuroiwa M, Yamashita S, Niho Y. Gastrointestinal angiodysplasia in congenital platelet dysfunction. Int J Hematol 1996; 65: 79-84.
14. Kluft C, Lansik M. Effect of oral contraceptives on hemostasis variables. Thromb Haemost 1997; 78: 315-22.
15. Mashchack CA, Lobo RA, Dozono-Takano R et al. Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol 1982; 144: 511-8.
16. Richtsmeier W, Weaver G, Streck W, Jacobson H, Dewell R, Olson J. Estrogen and progesterone receptors in hereditary hemorrhagic telangiectasias. Otolaryngol Head Neck Surg 1984; 92: 564-70.